Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Other hematologic neoplasm 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 142Leukemia 69Leukemia, Myeloid, Chronic-Phase 50Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Blast Crisis 22Philadelphia Chromosome 14Leukemia, Myeloid, Acute 12Leukemia, Myeloid, Accelerated Phase 12Leukemia, Myeloid 9Leukemia, Myelomonocytic, Chronic 7Primary Myelofibrosis 6Hematologic Neoplasms 6Myeloproliferative Disorders 5Hematologic Diseases 5Bone Marrow Diseases 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hypereosinophilic Syndrome 4Gastrointestinal Stromal Tumors 4Bronchiolitis Obliterans Syndrome 4Recurrence 3Polycythemia Vera 3Neoplasms 3Neoplasm, Residual 3Myelodysplastic Syndromes 3Lymphoma 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3

Interventions

nilotinib 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Piebaldism × Imatinib Mesylate × Other hematologic neoplasm × Clear all
NCT01126814 2015-06-24

A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia

University Health Network, Toronto

Phase 1/2 Completed
35 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Piebaldism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡